Search Results - "Dong, Zhouhuan"

A meta-analysis of circulating tumor DNA as a survival indicator in small cell lung cancer patients by Li, Jie, Wang, Liqun, Dong, Zhouhuan, Song, Qi, Wang, Zhanbo

“…A high level of circulating tumor DNA (ctDNA) has been linked to poor survival in patients with certain solid tumors. In spite of this, it is still unclear…”
Get full text

Primary hepatic myopericytoma coexisting with multiple cystic hepatic lesions: a case report by Yuan, Jing, Li, Jie, Dong, Zhouhuan, Xu, Wei, Wang, Zhanbo

“…Hepatic myopericytoma (MPC) is an extremely rare pathological entity in the liver. Conversely, cystic hepatic lesions are a group of heterogeneous lesions…”
Get full text

Analyzing the effects of BRCA1/2 variants on mRNA splicing by minigene assay by Dong, Zhouhuan, Wang, Yun, Zhang, Jing, Zhu, Fengwei, Liu, Zhiyuan, Kang, Yajun, Lin, Mingyuan, Shi, Huaiyin

“…As BRCA1/2 gene sequencing become more extensive, a large number VUS (variants of uncertain significance) emerge rapidly. Verifying the splicing effect is an…”
Get full text

Mutational signature and clonal relatedness of recurrent urothelial carcinomas with aristolochic acid by Zhu, Jie, Ai, Qing, Cheng, Qiang, Shen, Dan, Dong, Zhouhuan, Li, Jie, Shen, Donglai, Wang, Wei, Zhang, Xu, Li, Hongzhao

“…Urothelial carcinomas (UCs) are malignant tumors that arise from the lower and upper urinary tract and are characterized by multiple recurrences. Aristolochic…”
Get full text

Catalog of Lung Cancer Gene Mutations Among Chinese Patients by Xue, Xinying, Asuquo, Idorenyin, Hong, Lei, Gao, Jie, Dong, Zhouhuan, Pang, Li, Jiang, Tianjiao, Meng, Mingming, Fan, Jingbo, Wen, Jiaxin, Deng, Hui, Zang, Xuelei, Ma, Xidong, Guo, Rui, Qin, Chong, Meng, Yao, Ma, Heji, Han, Jun, Wang, Haijiao, Xue, Zhiqiang, Zhao, Dahai, Lin, Dongliang, Pan, Lei

“…Background: Detailed catalog of lung cancer-associated gene mutations provides valuable information for lung cancer diagnosis and treatment. In China, there…”
Get full text

Identification of genes for normalization of quantitative real-time PCR data in ovarian tissues by Fu, Jie, Bian, Lihong, Zhao, Li, Dong, Zhouhuan, Gao, Xin, Luan, Haofei, Sun, Yunjuan, Song, Haifeng

“…Increased attention has been paid to the determination of the potential biomarker and therapeutic target for ovarian cancer in recent years. However, the…”
Get full text

Complete remission through icotinib treatment in Non-small cell lung cancer epidermal growth factor receptor mutation patient with brain metastasis: A case report by Wang, Tao, Wang, Ruimin, Dong, Zhouhuan, Liang, Naichao, Chang, Ping

“…Brain metastasis (BM) has been universally recognized as a poor prognostic factor in non-small cell lung cancer (NSCLC). Epidermal growth factor receptor…”
Get full text

Effect of multi-omics analysis on tumor ecosystem during neoadjuvant dose-limiting chemotherapy combination with sequential PD-1 blockade for patients with esophageal cancer by Song, Qi, Yang, Bo, Xiong, Qi, Wang, Zhanbo, Long, Yaping, Dong, Zhouhuan, Zhou, Wenhao

“…e16085 Background: Patients with esophageal cancer benefited from neoadjuvant chemotherapy combined with immunotherapy. However, the sequence of administration…”
Get full text

Analysis of genomic alterations in pan-cancer from a large real-world Chinese population by Dong, Zhouhuan, Gao, Jie, Zhu, Fengwei, Gai, Fei, Su, Wenqing, Liang, Zhixin, Tian, Xiaodong, Shi, Huaiyin

“…10568 Background: Effective targeted therapy sorely depends on comprehensive and precise genomic profiling. Besides, single nucleotide variations (SNVs) and…”
Get full text

NMRK2 is an efficient diagnostic indicator for Xp11.2 translocation renal cell carcinoma by Feng, Huayi, Cao, Shouqing, Fu, Shihui, Liu, Junxiao, Gao, Yu, Dong, Zhouhuan, Cai, Tianwei, Wen, Lequan, Xiong, Zhuang, Li, Shangwei, Zhang, Xu, Ma, Xin, Li, Xiubin

“…Xp11.2 translocation renal cell carcinomas (tRCC) are a rare and highly malignant type of renal cancer, lacking efficient diagnostic indicators and therapeutic…”
Get full text

Patients with advanced non‑small cell lung cancer with EGFR mutations in addition to complex mutations treated with osimertinib have a poor clinical outcome: A real‑world data analysis by Chang, Nijia, Duan, Jingjing, Wang, Lingxiong, Dong, Zhouhuan, Liu, Zhefeng

“…The present study aimed to investigate the clinical characteristics and outcomes of patients with advanced non-small cell lung cancer (NSCLC) treated with…”
Get full text

Somatic mutation profiling and HER2 status in KRAS-positive Chinese colorectal cancer patients by Dong, Zhouhuan, Kong, Linghong, Wan, Zhiyi, Zhu, Fengwei, Zhong, Mei, Lv, Yali, Zhao, Po, Shi, Huaiyin

“…KRAS is an independent negative predictor for anti-epidermal growth factor receptor (anti-EGFR) treatment in colorectal cancers (CRCs). However, 30% to 50% of…”
Get full text

Correlation of lung immune prognostic index with the efficacy of immune checkpoint inhibitors in Chinese patients with advanced non-small cell lung cancer by Zhi, Xiaoyu, Zhang, Zhibo, Li, Weiwei, Dong, Zhouhuan, Wu, Xiaodong, Ge, Xiangwei, Zhai, Jinzhao, Lu, Di, Yan, Xiang, Wang, Jinliang

“…Purpose Treatment with immune checkpoint inhibitors (ICIs) improves the prognoses of patients with non-small cell lung cancer (NSCLC) but is ineffective in…”
Get full text

GLI1 activation is a key mechanism of erlotinib resistance in human non‑small cell lung cancer by Dong, Zhouhuan, Wang, Yun, Ding, Vivianne, Yan, Xiang, Lv, Yali, Zhong, Mei, Zhu, Fengwei, Zhao, Po, He, Charlotte, Ding, Feng, Shi, Huaiyin

“…Lung cancer is the leading cause of cancer-associated death worldwide. In recent years, the advancement of epidermal growth factor receptor-tyrosine kinase…”
Get full text

Effects of icotinib on early-stage non-small-cell lung cancer as neoadjuvant treatment with different epidermal growth factor receptor phenotypes by Wang, Tao, Liu, Yang, Zhou, Bin, Wang, Zhi, Liang, Naichao, Zhang, Yundong, Dong, Zhouhuan, Li, Jie

“…Epidermal growth factor receptor-tyrosine kinase inhibitors (EGFR-TKIs) have demonstrated efficacy in treating advanced non-small-cell lung cancer (NSCLC)…”
Get full text

GLI1 activation is a key mechanism of erlotinib resistance in human non-small cell lung cancer by Dong, Zhouhuan, Wang, Yun, Ding, Vivianne, Yan, Xiang, Lv, Yali, Zhong, Mei, Zhu, Fengwei, Zhao, Po, He, Charlotte, Ding, Feng, Shi, Huaiyin

“…Lung cancer is the leading cause of cancer-associated death worldwide. In recent years, the advancement of epidermal growth factor receptor-tyrosine kinase…”
Get full text

The different expression of glycogen phosphorylases in renal clear cell renal carcinoma and chromophobe renal carcinoma by Lu, Yang, Luo, Guangda, Zhu, Songbiao, Wang, Xu, Chen, Yuling, Dong, ZhouHuan, Wang, Shiyu, Ma, Jie, Deng, Haiteng, Wu, Di, Dong, Jun

“…The various pathogenesis between Clear cell renal carcinoma (CCRCC) and Chromophobe renal carcinoma (CHRCC) contributes to the different tumor growth rate and…”
Get full text

Heparanase DNA vaccine delivered by electroporation induces humoral immunity and cytoimmunity in animal models by Fu, Jie, Zhao, Bijun, Dong, Zhouhuan, Sun, Yunjuan, Luan, Haofei, Shen, Xianfei, Gao, Xin, Gong, Feng, Li, Subo, Song, Haifeng

“…Highlights ► Electroporation-assisted DNA vaccination targeting HPA proved to be effect therapeutic method. ► Humoral immunity and cytoimmunity were elicited…”
Get full text

Primary hepatic myopericytoma coexisting with multiple cystic hepatic lesions: a case report by Yuan, Jing, Li, Jie, Dong, Zhouhuan, Xu, Wei, Wang, Zhanbo

“…BACKGROUNDHepatic myopericytoma (MPC) is an extremely rare pathological entity in the liver. Conversely, cystic hepatic lesions are a group of heterogeneous…”
Get full text